Selzentry Maraviroc and/or alternatives
Selzentry 150mgMarketed as Celsentri in European Union Manufacturer: Pfizer Ltd Source Country : United Kingdom
Shipped from : United Kingdom
Selzentry 300mgMarketed as Celsentri in European Union Manufacturer: Pfizer Ltd Source Country : United Kingdom
Shipped from : United Kingdom
This item requires a prescription from your doctor
All trademarks and registered trademarks are the property of their respective owners.
Please note that the source country, shipping country and/or manufacture may vary depending on availability.
Description of Selzentry
Selzentry is an antiviral drug that prevents certain viral cells from multiplying further and is used along with other medications for treating medical conditions caused by HIV. Selzentry is classified as an entry inhibitor medication. Maraviroc is the drug’s generic name, and it is classified under a specific class of drugs known as HIV Entry and Fusion Inhibitors.
Selzentry is specifically meant for oral use. You can buy Selzentry in the form of film coated oral tablets in strengths of Selzentry 150mg or Selzentry 300 mg. The major ingredients in this drug are: soya lecithin, maraviroc, magnesium stearate, microcrystalline cellulose, talc and titanium dioxide, polyethylene glycol, dibasic calcium phosphate, etc.
Indications & Dosage of Selzentry
Selzentry may be prescribed as part of a combination of anti-HIV medications to decrease the amount of viral load i.e. HIV in a person’s blood. However this drug is inactive in treating patients with a CCR5-tropic HIV-1 infection.
The recommended dosage of Selzentry basically depends on the other medications that the patient is using at a particular point in time as the level of Selzentry in the patient’s body may be affected by the other drugs being taken. The Selzentry dosage recommended for adults is 150 mg or 300 mg to be taken two times daily based on individual requirements. Selzentry tablets must be swallowed whole without chewing or breaking them. They can be taken without food, but must always be used under the vigilance of one’s healthcare provider.
The oral tablets should be stored at temperatures ranging between 15°-30°C. The shelf life of Selzentry is approximately 24 months.
Side Effects & Interactions of Selzentry
Adverse effects associated with the usage of Selzentry include:
- low fever along with itching
- nausea, appetite loss and pain in the upper stomach
- dark urine and clay-colored stools
Patients can consult their doctors if they experience any of the following serious side effects while undergoing treatment:
- skin rash, severe tingling, bruising, numbness, pain, weakness in the muscles
- sudden numbness, weakness, or tingling anywhere in the body
- chest pain with pain spreading through the arm or shoulder, sweating, nausea, ill feeling
- cold sores or sores in the anal or genital area
- sores or white patches on the lips or inside the mouth
Complications may arise if you take Selzentry along with other drugs like Conivaptan (Vaprisol), Rifampin, Gleevec, Nefazodone, Isoniazid and etc. To prevent unwanted drug interactions, you should:
- Inform the doctor regarding the other medications you are currently taking
- Not take a new drug without informing the doctor beforehand
- Maintain a list of all the medicines you are using and share it with your doctor
Warnings & Precautions of Selzentry
Before you buy Selzentry, consult your doctor about the precautions and risk factors associated with the drug. You may experience increased chances of a heart attack or liver damage while taking this medicine.
The doctor must be informed of your medical history, especially if you have:
- Kidney disease
- Heart disease
- Liver disease, especially hepatitis B or C
- Circulation problems
- Low blood pressure
- Any other type of allergy
HIV positive women are advised against breastfeeding their babies as there is always a chance of passing on the HIV virus to the baby. Thus, you must not breastfeed while taking Selzentry, as the danger posed to the newborn is not known. You should consult your doctor about the best possible way of feeding your baby. The safety of Selzentry in the case of pregnant women has also not yet been established. If you are pregnant or planning to become pregnant during treatment, you must first talk to your healthcare provider.